GO:1902275 regulation of chromatin organization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902275 (regulation of chromatin organization) is a biological process that modulates the frequency, rate or extent of chromatin organization, encompassing assembly, disassembly and modification of chromatin architecture.
• Chromatin organization is regulated by ATP-dependent chromatin remodellers that use energy to slide, evict or restructure nucleosomes.
• Intrinsic and regulated phase separation of chromatin-binding proteins organizes chromatin into distinct compartments.
• Long non-coding RNAs and cohesin complexes are key regulators of chromatin organization in stemness and disease [2,5].
• Dysregulation of chromatin organization is linked to cancer, developmental disorders and cohesinopathies.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of chromatin regulators.
Description
Regulation of chromatin organization (GO:1902275) is a fundamental biological process that controls how DNA is packaged and accessed within the nucleus. It modulates the frequency, rate or extent of chromatin organization, including chromatin assembly, disassembly and modification. This process is essential for gene expression, DNA replication and repair, and its disruption is associated with numerous human diseases. Understanding the regulatory mechanisms of chromatin organization is critical for researchers in epigenetics, cancer biology and stem cell research. Recent studies have revealed that chromatin organization is governed by a combination of intrinsic biophysical properties and regulated interactions with protein complexes and non-coding RNAs [1,2,6]. This article provides a comprehensive overview of GO:1902275, covering its definition, mechanisms, key genes, disease relevance and research methods.
regulation of chromatin organization At A Glance
| GO ID | GO:1902275 |
|---|---|
| GO term | regulation of chromatin organization |
| Ontology | biological_process |
| Synonym | regulation of chromatin assembly/disassembly; regulation of chromatin modification; regulation of establishment or maintenance of chromatin architecture |
| Major function | Modulates the frequency, rate or extent of chromatin organization, including assembly, disassembly and modification |
| Related processes | Chromatin remodelling, histone modification, phase separation, cohesin-mediated loop formation |
| Key regulators | ATP-dependent chromatin remodellers, cohesin, long non-coding RNAs, phase-separating proteins |
| Disease relevance | Cancer, cohesinopathies, developmental disorders, neurodegeneration |
What Is GO:1902275?
According to the Gene Ontology, GO:1902275 (regulation of chromatin organization) is defined as any process that modulates the frequency, rate or extent of chromatin organization. This includes regulation of chromatin assembly/disassembly, chromatin modification, and the establishment or maintenance of chromatin architecture. In essence, it encompasses all molecular events that control how chromatin is structured and reorganized within the cell.
Why Is regulation of chromatin organization Important in Cell Biology?
Regulation of chromatin organization is crucial because it determines the accessibility of DNA to transcription factors, replication machinery and repair proteins, thereby influencing gene expression programs, cell fate decisions and genome stability [4,5]. Dysregulation of this process can lead to aberrant gene expression and has been implicated in a wide range of human diseases, including cancer and developmental syndromes. Moreover, understanding how chromatin organization is regulated provides insights into stem cell pluripotency and differentiation.
• Controls gene expression by regulating DNA accessibility.
• Essential for proper chromosome segregation and genome stability.
• Involved in stem cell maintenance and differentiation.
• Dysregulated in cancer, leading to abnormal gene expression.
• Mutations in cohesin complex cause cohesinopathies such as Cornelia de Lange syndrome.
• Phase separation of chromatin proteins contributes to nuclear organization.
• Long non-coding RNAs modulate chromatin organization in stemness.
• ATP-dependent remodellers are frequently mutated in cancer.
• Chromatin organization is critical for DNA repair and replication.
• Plant chromatin organization is regulated epigenetically in response to environment.
What Happens During regulation of chromatin organization?
ATP-dependent chromatin remodelling
In simple terms: Cells use energy to slide or remove nucleosomes, the protein spools that DNA wraps around, to open or close chromatin.
ATP-dependent chromatin remodellers are molecular machines that use the energy of ATP hydrolysis to alter nucleosome positioning, composition and structure, thereby regulating chromatin organization. These complexes can slide nucleosomes along DNA, evict histones, or exchange histone variants, directly impacting DNA accessibility.
Phase separation and chromatin compartmentalization
In simple terms: Some proteins spontaneously form droplets that organize chromatin into distinct regions.
Intrinsic and regulated phase separation of chromatin-binding proteins drives the formation of membraneless compartments that organize chromatin into active and repressive domains. This process is modulated by protein-protein and protein-DNA interactions, and can be regulated by post-translational modifications [1,6].
Cohesin-mediated chromatin looping
In simple terms: A ring-shaped protein complex holds DNA strands together to form loops, shaping the 3D genome.
The cohesin complex extrudes DNA loops to organize chromatin into topologically associating domains (TADs), which are critical for gene regulation and chromosome segregation. Mutations in cohesin subunits disrupt chromatin organization and cause human developmental disorders.
Long non-coding RNA regulation
In simple terms: RNA molecules that do not code for proteins can guide chromatin-modifying enzymes to specific locations.
Long non-coding RNAs (lncRNAs) interact with chromatin-modifying complexes and recruit them to specific genomic loci, thereby regulating chromatin organization and gene expression. This is particularly important in stem cells, where lncRNAs help maintain pluripotency or promote differentiation.
Epigenetic regulation of chromatin accessibility
In simple terms: Chemical tags on DNA and histones can change how tightly DNA is packed.
DNA methylation and histone modifications (e.g., acetylation, methylation) regulate chromatin accessibility by altering interactions between DNA and histones. These epigenetic marks are dynamically added and removed by enzymes, thereby modulating chromatin organization in response to developmental and environmental cues.
Key Genes Involved in GO:1902275 regulation of chromatin organization
The following genes encode key regulators of chromatin organization, including ATP-dependent remodellers, cohesin subunits, and chromatin-modifying enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMARCA4 | ATP-dependent chromatin remodeller (SWI/SNF subunit) | Frequently mutated in cancer; regulates nucleosome positioning |
| SMARCB1 | SWI/SNF subunit | Tumor suppressor; mutations in malignant rhabdoid tumors |
| CTCF | Chromatin insulator and looping factor | Organizes TADs; mutations in cancer and developmental disorders |
| SMC1A | Cohesin subunit | Mutations cause Cornelia de Lange syndrome |
| SMC3 | Cohesin subunit | Mutations cause cohesinopathies |
| RAD21 | Cohesin subunit | Mutations in cohesinopathy and cancer |
| STAG1 | Cohesin subunit | Cohesin complex component; role in loop extrusion |
| STAG2 | Cohesin subunit | Frequently mutated in cancer; regulates chromatin organization |
| HP1 (CBX5) | Heterochromatin protein | Binds H3K9me3; involved in phase separation |
| BRD4 | Bromodomain protein | Binds acetylated histones; regulates chromatin compaction |
| EZH2 | Histone methyltransferase | Catalyzes H3K27me3; regulates chromatin organization |
| KMT2A (MLL1) | Histone methyltransferase | Regulates H3K4me3; involved in leukemia |
| HDAC1 | Histone deacetylase | Removes acetyl groups; regulates chromatin accessibility |
| DNMT1 | DNA methyltransferase | Maintains DNA methylation; regulates chromatin organization |
| XIST | Long non-coding RNA | Regulates X-chromosome inactivation and chromatin organization |
| HOTAIR | Long non-coding RNA | Recruits PRC2 to regulate chromatin organization |
| NEAT1 | Long non-coding RNA | Forms paraspeckles; regulates chromatin organization |
How Is regulation of chromatin organization Regulated?
Regulation of chromatin organization is itself controlled by multiple mechanisms, including post-translational modifications of chromatin proteins, ATP-dependent remodelling, and phase separation [1,4]. For example, phosphorylation of chromatin remodellers can alter their activity and localization. Additionally, lncRNAs can recruit chromatin-modifying complexes to specific loci, thereby regulating chromatin organization. The process is also influenced by cellular metabolic states and environmental signals.
regulation of chromatin organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMARCA4 | Cancer (lung, ovarian) | Knockout in cancer cell lines; point mutation of ATPase domain |
| STAG2 | Cancer (bladder, myeloid) | Knockout in cancer cell lines; knock-in of patient mutations |
| SMC1A | Cornelia de Lange syndrome | Knock-in of patient mutations in iPSCs; knockout in zebrafish |
| EZH2 | Cancer (lymphoma) | Point mutation of catalytic domain; overexpression in cell lines |
| XIST | X-chromosome inactivation | Knockout in stem cells; overexpression in differentiated cells |
Cancer
Dysregulation of chromatin organization is a hallmark of cancer. Mutations in ATP-dependent chromatin remodellers, such as SMARCA4 and SMARCB1, are frequent in various cancers and lead to aberrant gene expression. Cohesin complex mutations, including STAG2, are also common in cancer and disrupt chromatin looping.
Cohesinopathies
Mutations in cohesin subunits (SMC1A, SMC3, RAD21) cause Cornelia de Lange syndrome and other cohesinopathies, characterized by developmental abnormalities. These mutations impair chromatin organization and gene regulation.
Neurodevelopmental disorders
Disruption of chromatin organization, particularly through mutations in chromatin remodellers and cohesin, is linked to neurodevelopmental disorders such as intellectual disability and autism.
Stem cell dysfunction
Long non-coding RNAs that regulate chromatin organization are critical for stem cell pluripotency and differentiation. Their dysregulation can lead to stem cell dysfunction and disease.
From regulation of chromatin organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SMARCA4 alter chromatin accessibility? | SMARCA4 knockout cell line |
| Does a specific point mutation in STAG2 affect cohesin function? | STAG2 point-mutation knock-in |
| How does overexpression of EZH2 affect chromatin organization? | EZH2 overexpression cell line |
| Does a disease-associated mutation in SMC1A disrupt chromatin looping? | SMC1A knock-in iPSCs |
| What is the role of XIST in chromatin organization? | XIST knockout and overexpression |
| Can CRISPR screening identify novel regulators of chromatin organization? | Genome-wide CRISPR library screening |
How to Study the regulation of chromatin organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Hi-C | 3D chromatin interactions | Detect TADs and loops regulated by cohesin |
| ATAC-seq | Chromatin accessibility | Assess open chromatin changes upon knockout |
| ChIP-seq | Protein-DNA binding | Map histone modifications and remodeller binding |
| Genome-scale imaging | 3D organization and transcription | Visualize chromatin compartments |
| Proteomics | Protein interactions and modifications | Identify chromatin complex components |
| RNA-seq | Gene expression | Measure transcriptional changes after perturbation |
| CRISPR screening | Gene function | Identify regulators of chromatin organization |
Genome-scale imaging of chromatin
Advanced imaging techniques, such as those described by Su et al. (2020), allow visualization of 3D chromatin organization and transcriptional activity at the genome scale. These methods provide spatial and functional insights into chromatin regulation.
Chromatin conformation capture (Hi-C)
Hi-C and related techniques measure physical interactions between genomic loci, revealing TADs and chromatin loops that are regulated by cohesin and CTCF.
ATAC-seq and DNase-seq
These assays measure chromatin accessibility by sequencing regions of open chromatin, providing a genome-wide view of regulatory elements and how they change upon perturbation of chromatin regulators.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify protein complexes associated with chromatin, such as remodellers and cohesin, and their post-translational modifications.
How CRISPR Can Be Used to Study GO:1902275 regulation of chromatin organization
Knockout
CRISPR knockout of chromatin regulator genes (e.g., SMARCA4, STAG2) enables loss-of-function studies to determine their role in chromatin organization and gene expression [4,5].
Point Mutation
Introducing specific point mutations (e.g., in the ATPase domain of SMARCA4 or in cohesin subunits) allows researchers to dissect the functional impact of disease-associated variants on chromatin organization [4,5].
Knock-in
Knock-in of tagged or mutant versions of chromatin regulators (e.g., GFP-tagged CTCF or patient mutations in SMC1A) facilitates live-cell imaging and functional studies [3,5].
Overexpression
Overexpression of chromatin regulators (e.g., EZH2, XIST) can model gain-of-function effects and study their impact on chromatin organization and gene expression [2,4].
How EDITGENE Supports regulation of chromatin organization Research
Researchers studying regulation of chromatin organization-related genes often need to determine whether a candidate gene is causally involved in chromatin structure and function. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of chromatin organization research.
Frequently Asked Questions About regulation of chromatin organization
What is GO:1902275 regulation of chromatin organization?
GO:1902275 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of chromatin organization, including assembly, disassembly and modification.
What genes are involved in regulation of chromatin organization?
Key genes include ATP-dependent chromatin remodellers (SMARCA4, SMARCB1), cohesin subunits (SMC1A, SMC3, RAD21, STAG1, STAG2), and chromatin-modifying enzymes (EZH2, KMT2A, HDAC1) [4,5].
How is chromatin organization regulated?
Chromatin organization is regulated by ATP-dependent remodelling, phase separation, cohesin-mediated looping, lncRNAs and epigenetic modifications [1,2,4,5].
What diseases are associated with dysregulation of chromatin organization?
Dysregulation is linked to cancer, cohesinopathies (e.g., Cornelia de Lange syndrome), neurodevelopmental disorders and stem cell dysfunction [2,5].
What methods are used to study regulation of chromatin organization?
Common methods include Hi-C, ATAC-seq, ChIP-seq, genome-scale imaging, proteomics and CRISPR screening [3,4,8].
How can CRISPR be used to study chromatin organization?
CRISPR knockout, point mutation, knock-in and overexpression models allow precise manipulation of chromatin regulator genes to study their function [4,5].
What is the role of phase separation in chromatin organization?
Phase separation of chromatin-binding proteins drives the formation of membraneless compartments that organize chromatin into active and repressive domains [1,6].
How do cohesin mutations affect chromatin organization?
Cohesin mutations disrupt DNA loop extrusion and TAD formation, leading to altered gene expression and developmental disorders.
What are long non-coding RNAs and how do they regulate chromatin?
Long non-coding RNAs are RNA molecules that do not code for proteins but can recruit chromatin-modifying complexes to specific genomic loci, thereby regulating chromatin organization.
Why is regulation of chromatin organization important for stem cells?
It controls the accessibility of genes required for pluripotency and differentiation, and its dysregulation can impair stem cell function.
Conclusion
Regulation of chromatin organization (GO:1902275) is a central biological process that governs genome function and cell fate. Its mechanisms involve ATP-dependent remodelling, phase separation, cohesin-mediated looping and non-coding RNA regulation. Dysregulation of this process contributes to cancer, developmental disorders and other diseases. Advanced CRISPR models and genomic methods are essential to dissect these mechanisms and develop therapeutic strategies.
References
- 1. Gibson BA et al.. 2019. Organization of Chromatin by Intrinsic and Regulated Phase Separation.. Cell 179(2):470-484.e21 PMID: 31543265
- 2. Dehghani H. 2021. Regulation of Chromatin Organization in Cell Stemness: The Emerging Role of Long Non-coding RNAs.. Stem Cell Rev Rep 17(6):2042-2053 PMID: 34181184
- 3. Su JH et al.. 2020. Genome-Scale Imaging of the 3D Organization and Transcriptional Activity of Chromatin.. Cell 182(6):1641-1659.e26 PMID: 32822575
- 4. Eustermann S et al.. 2024. Energy-driven genome regulation by ATP-dependent chromatin remodellers.. Nat Rev Mol Cell Biol 25(4):309-332 PMID: 38081975
- 5. Watrin E et al.. 2016. Gene regulation and chromatin organization: relevance of cohesin mutations to human disease.. Curr Opin Genet Dev 37:59-66 PMID: 26821365
- 6. Adame-Arana O et al.. 2023. Regulation of chromatin microphase separation by binding of protein complexes.. Elife 12 PMID: 37436818
- 8. Candela-Ferre J et al.. 2024. Mind the gap: Epigenetic regulation of chromatin accessibility in plants.. Plant Physiol 194(4):1998-2016 PMID: 38236303
